US, NEW YORK (ORDO NEWS) — Maryland-based Novavax said dosing for the Phase 1 clinical trial of its coronavirus vaccine candidate would begin Monday, FOX news reports.
“Administering our vaccine in the first participants of this clinical trial is a significant achievement, bringing us one step closer toward addressing the fundamental need for a vaccine in the fight against the global COVID‑19 pandemic,” Novavax President and CEO Stanley C. Erck said in a statement.
“We look forward to sharing the clinical results in July and, if promising, quickly initiating the Phase 2 portion of the trial.”
This is a breaking news, we are working and more details will be published as soon as they are available… please refresh the page or go to IN THE NEWS to see latest updates.
Contact us: [email protected]